Skip to content
Home›Awards›Sagent Pharmaceuticals, INC
$

Federal Contract Award

Sagent Pharmaceuticals, INC

Department of Defense · May 20, 2026 · FY2026

SPE2D326F135BSet-aside not reportedNAICS 325411

Obligated

$48

Contract details

Award ID
CONT_AWD_SPE2D326F135B_9700_SPE2D021D0003_9700
PIID
SPE2D326F135B
Period of performance
May 20, 2026 → May 21, 2026
Place of performance
SCHAUMBURG, IL, USA
Set-aside
Not reported
Pricing type
FIRM FIXED PRICE
PSC
6505 — DRUGS AND BIOLOGICALS
NAICS
325411 — MEDICINAL AND BOTANICAL MANUFACTURING

Scope

4571894571!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML

Parent vehicle (IDV)

Nichi-iko Pharmaceutical Co.,ltd.

UEI YDRLCQE4AJE7

This award was placed as a task/delivery order under a larger contract vehicle.

Recipient

Sagent Pharmaceuticals, INC →
UEI
PR1HCLM3FMW7
CAGE
4RP13
Parent
Nichi-iko Pharmaceutical Co.,ltd.
Address
SCHAUMBURG, IL

Awarding agency

Department of Defense →
Sub-agency
Defense Logistics Agency
Office
DLA TROOP SUPPORT
Funding agency
Department of Defense
Funding office
DLA TROOP SUPPORT

See every contract Sagent Pharmaceuticals, INC has won

Full contracting history, year-over-year trends, subaward graph, and recompete alerts.

View Sagent Pharmaceuticals, INC profile →